Can Basilea’s Antibiotic Succeed Where Others Have Failed?

Company Looks To Partner Ceftobiprole Ahead Of US Approval

 
• By Alaric DeArment
Basilea announced Phase III results in serious Staphylococcus aureus infections • Source: Shutterstock

More from Strategy

More from Business